Most immunosuppressives used at present (X-rays, alkylating agents, antimetabolites, cytotoxic antibiotics) have a common mode of action at the cellular level, acting largely by damaging cell reproductive integrity (Berenbaum 1971 ). However, they achieve this result by very different biochemical actions and I propose to discuss some of the consequences of this.
The relevant biochemical effects of these agents can broadly be divided into effects on DNA templates and effects on enzymes concerned in cell proliferation (mainly enzymes directly or indirectly involved in DNA synthesis).
Template Effects
The agents that damage the DNA template are ionizing radiation, alkylating agents (cyclophosphamide, chlorambucil, &c.) and some antibiotics that are converted to alkylating agents in vivo (e.g. mitomycin). Radiation breaks the DNA chain by producing an ionization in its vicinity (Alexander & Stacey 1958) . Alkylating agents crosslink the DNA chain either to its partner in the double helix or to adjacent protein (Lawley & Brookes 1967 , Roberts et al. 1968 . A broken or crosslinked DNA strand cannot properly act as a template for DNA synthesis. However, cells can repair such lesions and the reproductive ability of cells exposed to X-rays or alkylating agents therefore depends not only on the initial damage but also on the extent to which it is corrected before the next round of DNA synthesis (Roberts et al. 1968 , Alexander 1969 .
The fact that a DNA chain has been broken or crosslinked at one point by a quantum of radiation or a molecule of alkylating agent does not affect its liability to be broken or crosslinked at other points by other quanta or molecules. Accordingly, the lesions caused by these agents are random and independent of each other.
Enzyme Effects
The agents that interfere with the enzymes concerned in cell replication are the antimetabolites (6-mercaptopurine, azathioprine, methotrexate, &c.). These structurally resemble natural enzyme substrates and so can fit the substratebinding sites on enzyme molecules. Sometimes they resemble the product of an enzyme reaction and, like the natural product, can inhibit the reaction by combining with the enzyme at a site other than the substrate-binding site. If a site on an enzyme molecule is occupied, whether by a molecule of antimetabolite, substrate or product, it cannot simultaneously be occupied by another molecule. Accordingly, there is an element of competition in the action of antimetabolites. Unlike the behaviour of a quantum of radiation or a molecule of alkylating agent, which is independent of the behaviour of other quanta or molecules, the behaviour of a molecule of antimetabolite depends directly on the behaviour of other molecules of antimetabolite, substrate or product.
Dose-response Curves
One clinically important consequence of this difference in modes of action is that different dose-response curves result. How these are generated will be illustrated by two analogies. X-Rays and alkylating agents: Our analogy for an agent causing random and independent lesions is a spray of bullets from an unaimed machinegun. A 'dose' of bullets is fired at random, sufficient to hit half of a particular group of individuals (leaving half unhit). If a second, equal 'dose' were fired, either subsequently or simultaneously, we would expect it again to hit half the individuals. As these lesions are random and independent of each other, half of those hit by the second round would already have been hit by the first, and half would consist of individuals missed by the first round, so a quarter of the group would still be unhit. A third round would again hit half the individuals indiscriminately (i.e. half of those already hit once, and half of those so far unhit). This would leave one-eighth of the group unhit. (Strictly speaking, a 'dose' of bullets sufficient to hit half the members of a group will not hit each one with a single bullet. Some will have two or more hits. However, this does not affect the argument.)
The process is illustrated in Fig 1A. If one hit were sufficient to kill, half the group would survive one dose, a quarter would survive two doses, an eighth three doses, and so on. Plotting these results with dose on a linear scale and survival on a logarithmic scale gives a straight line (Fig 2A) . This is a so-called exponential curve, and typifies the effects of radiation and alkylating agents on cell survival (Lea 1955 , Alexander 1969 , Berenbaum 1969a . Commonly such curves have a shoulder at low doses, readily explained by the ability of cells to repair damage. For each individual could recover from the effects of one bullet but is killed by two, the survival curve, which can be read off Fig IA and is shown as a curve in Fig 2B, has an obvious shoulder at low doses but tends to straighten out at higher doses to parallel the curve of Fig 2A. Antimetabolites: Our analogy for antimetabolite action is the supplying of poisoned drinks to the group of individuals upon whose destruction we are bent. Each individual can have only one drink, and cannot distinguish between poisoned drinks and the more orthodox kind. If equal numbers of poisoned and normal drinks are supplied, each individual has a 50 % chance of surviving. If there are two poisoned drinks for every normal one, 1 individual in 3 will survive, and if there are four poisoned drinks for each normal one, 1 individual in 5 will survive. The process is shown in Fig 1B. If the results are plotted as before, we have a curve with continuously decreasing slope (Fig 2c) . Such curves are typical of the effects of antimetabolites on proliferating cell populations (Berenbaum 1969a) . (Strictly speaking, this analogy refers to the relation between antimetabolite concentration and enzyme inhibition, and not directly to the relation between antimetabolite dose and cell reproductive integrity. However, there must be a direct relation between these two levels of antimetabolite action when enzymes crucial for cell reproduction are concerned.) Therapeutic Consequences Consider first Fig 2B. Because individuals or cells in this example can repair a small amount of damage, a low dose which hits a large proportion of its targets only once is relatively ineffective, as shown by the shoulder on the curve. The larger the dose, the greater the proportion of targets hit In this example each unit dose ofagent hits halfthe targets indiscriminately (a hit is indicated by a bar across the target). With successive linear increments in dose the chances ofa target remaining unhitfallfrom one to a haf, quarter, eighth, andso on. B, generation ofa dose-response curve typical ofantimetabolites. The substrate-binding site can be occupied by only one molecule at a time, whether ofnormal substrate (0) or antimetabolite (@). With successive linear increments in dose, the chances ofa binding site being occupied by the normal substratefall from one to a half, third, quarter,fifth, andso on. D, dose. S,fraction surviving with normal activity Fig A, assuming that a cell can repair the damage due to one hit but is inactivated by two hits. c, hyperbolic type of dose-response curve derivedfrom Fig IB   more than once, the less the chance of complete repair, and the greater the resulting effect. Evidently, with agents giving this type of doseresponse curve, it pays to give massive doses.
The converse is true in Fig 2c. In the high dose range, large increments in dose produce relatively little increase in effect. The greatest ireturn for dose administered is in the lower dose range. Accordingly, if one compares various dose regimens in which the same total amount of drug is given over the same period, antimetabolites will tend to have more effect if the doses are small and frequent, while alkylating agents are likely to have more effect if doses are massive and few. When the curve is like that in Fig 2A, as it is sometimes with radiation and alkylating agents, the total effect should be independent of the manner of dose division.
Although these considerations tell us something about effects on proliferating cells in general, they say nothing about the relative effects on different cell populations. As most immunosuppressive agents damage not only immunocytes but also other proliferating cell populations (myelopoietic cells, intestinal epithelium, &c.) we have to take the relative effects on different cell populations into account in therapy (Berenbaum 1969b ). However, there are a few agents whose selectivity for a particular cell type is so great that only effects on these cells need be considered. Antilymphocyte serum (ALS) is one such agent, its effects on nonlymphoid cells usually being negligible. The doseresponse curve for ALS resembles that in Fig 2c (although its mechanism of action is quite different from that of antimetabolites). We would therefore expect that a limited amount of ALS would be more effective if divided into several small doses than if given as a single large dose. This expectation has been confirmed in experi-ments on antibody production and graft rejection in mice .
The analysis of dose-response curves of immunosuppressive, agents and their consequences has only just begun. Further study is likely to increase our understanding of the ways in which these agents act and enable us to use them more effectively.
